SEC Form D private-offering filing

Natsar Pharmaceuticals, Inc.

Name: Natsar Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Ellicott City, MD
Published: 2026-05-08

A new SEC Form D private-offering notice from Ellicott City, MD, an undisclosed offering target in Biotech. The source filing is one click away.

Natsar Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Drug development company researching small molecule inhibitors that target cancer related cellular pathways.

Filed 2026-05-08Filed to raise UndisclosedFirst money in 2026-04-23Raised so far $4,221,000HQ (as filed) Ellicott City, MDSector Biotech ✓Stage (inferred) SeedCall status Needs classification

Source linked the Form D on EDGAR↗Website verified natsarpharmaceuticals.com↗Named in the filing 1 executive & director

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.